Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Hypertension Receiving Bevacizumab for Breast Cancer
Clinical trial NCT02610413 · RECRUITING
Trial details
- NCT number
- NCT02610413
- Sponsor
- National Cancer Institute (NCI)
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2014-03-25
- Primary completion
- 2100-01-01
- Enrollment
- 354
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.